CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
UL
Unilever PLC
There isn't enough reported data to score UL yet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
UL Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Stable |
UL's profitability is currently strong, and its balance sheet is stable. There isn't enough data to rate its revenue and cash flow.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
UL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 14x | $66.03 | — |
| Cheap | 15x | $70.78 | +7.2% |
| Fair | 21x | $99.84 | +51% |
| Expensive | 23x | $111 | +68% |
Historical ranges are pointers, not guarantees.
UL has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
UL Forward outlook
There aren't enough analyst estimates for UL to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over UL in the latest year-over-year earnings comparison.
UL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $4.80 | +68% |
| Q2 2025 | $2.80 | -15% |
| Q4 2024 | $2.86 | -11% |
| Q4 2023 | $3.20 | -14% |
| Q4 2022 | $3.74 | +29% |
| Q4 2021 | $2.90 | +9.4% |
| Q2 2021 | $2.58 | -8.2% |
| Q4 2020 | $2.65 | -1.1% |
UL earned $4.80 per share over the past year, up 50% from the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
UL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $56.1B | +70% |
| Q2 2025 | $33.5B | -3.2% |
| Q4 2024 | $32.9B | +1.6% |
| Q2 2024 | $34.6B | +2.3% |
| Q4 2023 | $32.4B | -51% |
| Q4 2022 | $66.7B | +125% |
| Q4 2021 | $29.6B | +6.6% |
| Q2 2021 | $28.7B | +0.3% |
UL has the edge over CELH in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 18% | +3.4 points |
| Q2 2025 | 18% | -0.5 points |
| Q4 2024 | 12% | -6.3 points |
| Q2 2024 | 19% | +3.1 points |
| Q4 2023 | 15% | -2.6 points |
| Q2 2023 | 18% | +3.6 points |
| Q4 2022 | 18% | -0.3 points |
| Q4 2021 | 16% | +0.1 points |
UL's operating margin was 18% last quarter, up 3.4 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
UL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $7.7B | +38% |
| Q2 2025 | $1.8B | -42% |
| Q4 2017 | $6.4B | +38% |
| Q4 2016 | $4.6B | +3% |
| Q2 2016 | $1.2B | -24% |
| Q4 2015 | $4.5B | +51% |
| Q2 2015 | $1.6B | +47% |
| Q4 2014 | $3B | -11% |
UL's free cash flow has been positive every quarter since mid-2011: $18.1B over the past year, down 3.3% from the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
UL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -902K shares |
| 1 year | -2.4% | -53.5M shares |
| 3 years | -9.7% | -235M shares |
| 5 years | -25% | -727M shares |
| Available history | -25% | -713M shares |
UL has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2018 | $2.8B |
| Q4 2016 | — |
| Q2 2016 | $288.8M |
| Q4 2015 | $153.3M |
| Q2 2015 | $153.3M |
| Q4 2014 | $234.4M |
| Q2 2014 | $284.4M |
| Q4 2013 | $4.4M |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
UL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 2.1x | Moderate |
UL's net debt is about 2.1 years of its operating earnings (EBITDA).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
UL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.5 | Neutral |
| Stochastic | 70.3 | Neutral |
UL's weekly RSI is 58 (neutral) and its Stochastic is 70 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
UL PE vs Consumer Defensive Sector
| Metric | UL | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 19x | 29% below |
| PE % | 12 | 18 | 6 pts below |
UL has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
UL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $64.3 | 2.7% above |
| 20 week MA | $63.4 | 4.2% above |
| 50 week MA | $63.2 | 4.5% above |
| 100 week MA | $65.5 | 0.7% above |
| 200 week MA | $62.8 | 5.2% above |
UL has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
UL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $65.0 | $66.1 | +1.7% |
| 2021 | $66.1 | $59.5 | -10% |
| 2022 | $59.5 | $57.5 | -3.3% |
| 2023 | $57.5 | $54.6 | -5.1% |
| 2024 | $54.6 | $64.7 | +19% |
| 2025 | $64.7 | $66.2 | +2.3% |
| 2026 YTD | $66.2 | $66.0 | -0.2% |
UL has the edge over CELH on returns for 2026, with the stronger performance.